Meturedepa is an antineoplastic agent. References: Moore GE, Bross ID, Ausman R, Nadler S, Jones R Jr, Slack N, Rimm AA. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother Rep. 1968 Oct;52(6):667-73. PubMed PMID: 4895430.

纯度：≥98%

CAS：1661-29-6